Abstract:273 Objectives: explore the value of radiomics analysis based on 18F-FDG and 18F-FLT PET/CT images in the differentiation of benign and malignant pulmonary nodules (PNs). Methods: We retrospectively analyzed 113 patients getting clinicians into trouble of differential diagnosis between benign and malignant PNs on 18F-FDG PET/CT images, all of whom were followed by additional preoperative 18F-FLT PET/CT scans within a week. Three analysis methods including visual analysis, radiomics analysis based on 18F-FDG PET/CT images alone and radiomics analysis based on dual tracer PET/CT images were evaluated in the differential diagnostic value of benign and malignant PNs. Radiomics analysis went in details like dividing the dataset into training set and test set in a ratio of 7:3 (The distribution of the dataset was shown in Table 1), extracting specific quantitative features via analysis of variance (ANOVA) and least absolute shrinkage and selection operator (LASSO), constructing the logistic regression (LR) model, and evaluating their performances via receiver operating characteristic (ROC), sensitivity and specificity. Results: A total of 123 lesions were acquired from 113 patients (74 men, 39 women; mean age 56.4 years; age range, 27-83 years). To be more detailed, 63 benign lesions were respectively diagnosed as inflammation (n=12), tuberculosis (n=29), or other diseases confirmed by follow-up (n=22) while 60 malignant lesions included adenocarcinoma (n=30), squamous cell carcinoma (n=16), small cell carcinoma (n=1), bronchioloalveolar carcinoma (n=6) and others (n=7), as presented in Table 2. Based on visual analysis of 18F-FDG PET/CT images,the diagnostic accuracy, sensitivity and specificity were 61.6%, 90% and 28.8% respectively. 678 radiomics features (see Supplemental Table) were extracted from Volumes of Interest (VOIs) of PNs (The process was revealed in Fig. 1). And 19 features were selected by ANOVA. After LASSO optimization, 14 valuable features were screened out (Fig. 2 shows the above two steps). As vividly indicated in Fig. 3, based on 18F-FDG PET/CT plus 18F-FLT signature, the area under the curve (AUC), sensitivity and specificity under the test set are 0.838, 0.778, and 0.750 respectively while under the training set, they are 0.879, 0.810, and 0.750 successively. And based on 18F-FDG PET/CT, the AUC, sensitivity and specificity under the test set are 0.810, 0.778, and 0.688 respectively while under the training set, they are 0.834, 0.786, and 0.778 successively (The results were listed in Table 3). Conclusions: Radiomics analysis based on dual-tracer PET/CT images may be clinically potential and feasible for the discernable evaluation of benign and malignant PNs.

PET Morphology Helps Distinguish Solitary and Solid Pulmonary Tuberculosis from Non-Small Cell Lung Cancer

Ability of 18F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma

Fluorodeoxyglucose-positron emission tomography/computed tomography features of suspected solitary pulmonary lesions in breast cancer patients following previous curative treatment.

Diagnostic Performance of 18F-FDG Positron Emission Tomography/Computed Tomography and Blood Test Parameters for Pulmonary Inflammatory Pseudotumor

Positron Emission Tomography Molecular Imaging for Phenotyping and Management of Lymphoma

Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging

Comparison Of Positron Emission Tomography Using 2-[F-18]-Fluoro-2-Deoxy-D-Glucose And 3-Deoxy-3-[F-18]-Fluorothymidine In Lung Cancer Imaging

Differential Diagnosis of Pulmonary Tuberculomas and Malignant Nodules Using 18F-FLT and 18F-FDG PET/CT Imaging

Pitfalls of Fluorodeoxyglucose Positron-Emission Tomography-Ct in Tuberculosis Mimicking Malignancy in 60 Patients

Value of Dynamic Metabolic Curves and Artificial Neural Network Prediction Models Based on 18F-FDG PET/CT Multiphase Imaging in Differentiating Nonspecific Solitary Pulmonary Lesions: a Pilot Study.

Role of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Newly Found Suspected Malignant Solitary Pulmonary Lesions in Patients Who Have Received Curative Treatment for Colorectal Cancer.

Quantitative parameters of static imaging and fast kinetics imaging in <SUP>18</SUP>F-FDG total-body PET/CT for the assessment of histological feature of pulmonary lesions

Evaluation of the diagnostic efficacy of 18 F-Fluorine-2-Deoxy-D-Glucose PET/CT for lung cancer and pulmonary tuberculosis in a Tuberculosis-endemic Country

Predicting solitary pulmonary lesions in breast cancer patients using 18fluorodeoxyglucose-positron emission tomography/computed tomography combined with clinicopathological characteristics

Differential diagnosis of lung cancer and tuberculosis based on 18F-fluorodeoxyglucose PET/CT multi-time points imaging.

Comparison of Imaging Features of 18F-FDG PET/CT in Malignant Pleural Effusion and Tuberculosis Pleural Effusion

Radiomics Analysis Based on 18F-FDG and 18F-FLT PET/CT Images May Facilitate the Differentiation of Benign and Malignant Pulmonary Nodules

[FDG-PET in the Diagnosis of Pulmonary Lesions].

(18)~F-FDG PET-CT imaging characteristic analysis of pulmonary tuberculosis

Can Multimodality Imaging Using 18F-FDG/18F-FLT PET/CT Benefit the Diagnosis and Management of Patients with Pulmonary Lesions?

18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging features in patients with non-tuberculous mycobacterial infection